Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Landos Biopharma Inc LABP

Healthcare
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of novel, oral, once-daily therapeutics for patients with autoimmune diseases. It is engaged in the development of therapeutics that target novel pathways at the interface of immunity and metabolism. Its lead product candidate is NX-13, a novel, oral, gut-selective, NLRX1 agonist. It is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LABP)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHRD, AA, FUSN, LABP

PR Newswire 2 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN

Accesswire 3 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LABP, ADTH, MODN, SCX

PR Newswire 7 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IP, LABP, MCBC, HRT

Accesswire 8 days ago

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie

PR Newswire 9 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT

PR Newswire April 9, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA

PR Newswire April 5, 2024

Lifshitz Law PLLC Announces Investigations of KTRA, CHX, PIK, and LABP

Accesswire April 5, 2024

SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.

Accesswire April 4, 2024
View More News ››

Opinion & Analysis (NDAQ:LABP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LABP)

Check this out.

Quite an interesting read.  Maybe we will get rich afterall. Landos Biopharma Reports Third Quarter 2022 Results and Provides...
dodobee - November 10, 2022

What's Happening?!

What's going on?  It traded four and a half million shares today and many more millions in the last few days.  Does anybody...
dodobee - November 2, 2022

Question?

Does anybody out there know what's going on?  Is it a buy or sell?
dodobee - October 20, 2022

Curiosity

I have been watching this stock for quite a while now and I am wondering if anyone can indicate what the future of it might be?  I...
dodobee - October 17, 2022
View more Bullboard ››

Nexera Energy Inc

Nexera Energy Inc

Nexera Energy Inc. is a Canada-based energy company with oil producing properties in southwest Texas. The Company is engaged ...
View More »